Our mission is to create groundbreaking cancer immunotherapies that offer hope for curing refractory cancers, and ultimately reduce the suffering of cancer patients. At the core of our development pipeline is a cancer vaccine utilizing Sonanos™, a hyaluronic acid nanogel with immune cell-targeting capabilities. Furthermore, we are advancing the development of a combination therapy with Sonanos™ cancer vaccine and genetically engineered T-cell therapy, offering potential for remission and prevention of recurrence in refractory cancers.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://diveradgel.co.jp/
Diveradgel Co., Ltd. Questions
Diveradgel Co., Ltd.'s website is https://diveradgel.co.jp/
Diveradgel Co., Ltd.'s LinkedIn profile is https://www.linkedin.com/company/diveradgel-co-ltd
Diveradgel Co., Ltd.'s industry is
Pharmaceutical Manufacturing
Diveradgel Co., Ltd.'s top competitors are
Gel Coat Biomaterials, Inc.,
Ixgene Inc.,
Cyto-Facto Inc.,
Ferroptocure Inc.,
Ibody Inc.,
Chiome Bioscience,
Divamics Inc.,
Starna Therapeutics,
Cic (Cambridge Innovation Center),
Biosimax Lifesciences Ltd.
Diveradgel Co., Ltd.'s categories are Pharmaceutical Manufacturing
